EGFR Inhibitor Market to Accelerate Substantially During the Study Period (2020–2034) | DelveInsight
April 22, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 22, 2024 (GLOBE NEWSWIRE) -- EGFR Inhibitor Market to Accelerate Substantially During the Study Period (2020–2034) | DelveInsight According to DelveInsight’s analysis, the...
Les Vêtements de Sport Gildan annonce un renouvellement du conseil pour soutenir Vince Tyra, le chef de la direction, et Gildan dans la prochaine phase de croissance durable
April 22, 2024 05:00 ET
|
Les Vêtements de Sport Gildan Inc.
Le renouvellement du conseil reflète les commentaires des actionnaires et fait suite au défaut de Browning West de participer de façon constructive dans le cadre d’une course aux procurations inutile ...
Gildan Activewear Announces Board Refreshment to Support CEO Vince Tyra and Gildan’s Next Phase of Sustainable Growth
April 22, 2024 05:00 ET
|
Gildan Activewear, Inc.
Board Refreshment Reflects Shareholder Feedback and Follows Browning West’s Failure to Constructively Engage as it Pursues a Needless and Wasteful Proxy Contest Browning West is Attempting to Take...
Media Recap: Motion Pictures - The Jerry Schatzberg Archive Grand Opening at Morrison Hotel Gallery New York City
April 18, 2024 09:00 ET
|
Morrison Hotel Gallery
NEW YORK, April 18, 2024 (GLOBE NEWSWIRE) -- Morrison Hotel Gallery proudly announces the addition of iconic photographer and film director Jerry Schatzberg to its esteemed roster of artists. In...
HER2+ Market to Accelerate Substantially by 2034, Predicts DelveInsight | Key Companies - Zymeworks, Jazz Pharmaceuticals, Ambrx, AnBogen Therapeutics, Enliven Therapeutics, Roche
April 17, 2024 13:00 ET
|
DelveInsight Business Research LLP
New York, USA, April 17, 2024 (GLOBE NEWSWIRE) -- HER2+ Market to Accelerate Substantially by 2034, Predicts DelveInsight | Key Companies - Zymeworks, Jazz Pharmaceuticals, Ambrx, AnBogen...
Acute Lymphocytic Leukemia (ALL) Pipeline Landscape Report 2024: Comprehensive Insights About 250+ Companies and 250+ Pipeline Drugs
April 16, 2024 04:59 ET
|
Research and Markets
Dublin, April 16, 2024 (GLOBE NEWSWIRE) -- The "Acute lymphocytic leukemia (ALL) - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This "Acute...
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
April 15, 2024 08:30 ET
|
IO Biotech
IO Biotech Expands Senior Leadership Team to Progress Commercialization Readiness
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami
April 15, 2024 08:00 ET
|
London Research and Pharmaceuticals
London Research & Pharmaceuticals Corp. Presents the Advancement of their Oral Cannabidiol Sulphate Drug Candidate at Epilepsy Therapies Conference
Harju Maakohus jättis rahuldamata Jazz Pesulad OÜ, Olerex AS, Hotell Euroopa OÜ, EfTEN SPV2 OÜ, EfTEN Sky OÜ, Kadrioru Ärikeskus OÜ, Solaris Keskus AS, Hotell Olümpia AS ja Central Hotell OÜ poolt AS Tallinna Vesi suhtes esitatud hagi
April 11, 2024 06:11 ET
|
Tallinna Vesi
Harju Maakohus langetas täna otsuse, mille alusel jättis rahuldamata Jazz Pesulad OÜ, Olerex AS, Hotell Euroopa OÜ, EfTEN SPV2 OÜ, EfTEN Sky OÜ, Kadrioru Ärikeskus OÜ, Solaris Keskus AS, Hotell...
Harju County Court dismissed the claim submitted by Jazz Pesulad OÜ, Olerex AS, Hotell Euroopa OÜ, EfTEN SPV2 OÜ, EfTEN Sky OÜ, Kadrioru Ärikeskus OÜ, Solaris Keskus AS, Hotell Olümpia AS and Central Hotell OÜ
April 11, 2024 06:11 ET
|
Tallinna Vesi
Harju County Court passed today judgement, dismissing the claim submitted by Jazz Pesulad OÜ, Olerex AS, Hotell Euroopa OÜ, EfTEN SPV2 OÜ, EfTEN Sky OÜ, Kadrioru Ärikeskus OÜ, Solaris Keskus AS,...